The Evolving Clinical Spectrum of Diabetic Neuropathy
Saturday, June 24, at 3:15 p.m. PT
Room 25
San Diego Convention Center
Presentation: Update on Mechanisms
Mark A. Yorek, PhD
Professor of Medicine,
University of Iowa
What is your presentation about?
I will present new information on the current mechanisms thought to contribute to development of diabetic peripheral neuropathy (DPN). There is no treatment for DPN and a better understanding of the etiology is needed to develop a treatment. Such treatment will likely require a combination of interventions.
What makes this topic important in 2023?
Diabetic peripheral neuropathy is the most prevalent of diabetes complications. It is the leading cause of non-trauma related amputations. A better understanding of its etiology is needed for determining an effective treatment.
How did you become involved with this area of diabetes research or care?
As a graduate student I was trained in carbohydrate metabolism and studied lipid metabolism as a postdoctoral student. This combination of studies was a normal transition into diabetes research.
How do you think your presentation will impact diabetes research or care?
The main point I hope attendees take away from my presentation is that an effective treatment for diabetic peripheral neuropathy will likely require a combination of pharmaceutical and life altering therapies.
What are you most looking forward to at the 83rd Scientific Sessions?
Research updates and meeting with colleagues.